Apoptosis pathways in neuroblastoma therapy
Simone Fulda1, Klaus Michael Debatin
1University Children's Hospital, Prittwitzstr. 43, D-89075 Ulm, Germany.
Abstract:
Apoptosis, the cell's intrinsic death program, plays a crucial role in the regulation of tissue homeostasis, and an imbalance between cell death and proliferation may result in tumor formation. Also, killing of tumor cells by diverse cytotoxic approaches such as anticancer drugs, gamma-irradiation, suicide genes or immunotherapy, is predominantly mediated through induction of apoptosis. Failure to activate apoptotic pathways in response to drug treatment may lead to resistance of neuroblastoma cells to anticancer therapies. Understanding the molecular events that regulate apoptosis induced by cytotoxic therapies and how neuroblastoma cells evade apoptotic events may provide a new paradigm for neuroblastoma therapy. Thus, novel strategies targeting resistance of neuroblastoma cells will be based on insights into the molecular mechanisms of apoptosis as well as other forms of cell death.
Insights
Apoptosis, or programmed cell death, is vital for tissue balance. Understanding how neuroblastoma cells resist apoptosis is key to developing new cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Cell Death Research
Background:
- Apoptosis, the body's programmed cell death process, is essential for maintaining tissue homeostasis.
- Dysregulation of apoptosis, leading to an imbalance between cell death and proliferation, is a hallmark of tumor formation.
- Many cancer treatments, including chemotherapy and radiation, induce cancer cell death primarily through apoptosis.
Purpose of the Study:
- To investigate the molecular mechanisms underlying apoptosis induction in cancer therapy.
- To understand how neuroblastoma cells evade apoptosis, leading to therapeutic resistance.
- To identify novel therapeutic strategies targeting apoptosis resistance in neuroblastoma.
Main Methods:
- Review of current literature on apoptosis and cancer therapy.
- Analysis of molecular pathways involved in apoptosis regulation.
- Examination of resistance mechanisms in neuroblastoma cells.
Main Results:
- Impaired apoptosis activation is a significant factor in neuroblastoma's resistance to anticancer treatments.
- Understanding the molecular basis of apoptosis evasion is crucial for overcoming treatment failure.
- Insights into apoptosis and alternative cell death pathways can guide the development of new therapeutic approaches.
Conclusions:
- Targeting apoptosis resistance mechanisms in neuroblastoma offers a promising avenue for improving treatment efficacy.
- Further research into the molecular intricacies of cell death pathways is essential for advancing neuroblastoma therapy.
- Novel therapeutic strategies should focus on overcoming neuroblastoma's ability to evade programmed cell death.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
